Increased expression of TRAIL and its death receptors DR4 and DR5 in plaque psoriasis

Archives of Dermatological Research

Volumn 303, Issue 6, 2011, Pages 389-397

  Peternel, Sandra ^a   Prpić Massari, Larisa ^a   Manestar Blažić, Teo ^a   Brajac, Ines ^a   Kaštelan, Marija ^a  

^a UNIVERSITY OF RIJEKA   (Croatia)

Author keywords

Dendritic cells; Macrophages; Psoriasis; T cells; TNF related apoptosis inducing ligand; TRAIL receptors

Indexed keywords

CD16 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD68 ANTIGEN; CD8 ANTIGEN; DEATH RECEPTOR; DEATH RECEPTOR 4; GLYCOPROTEIN P 15095; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFLAMMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PSORIASIS VULGARIS; SKIN BIOPSY; SKIN DEFECT;

ADULT; ANTIGENS, CD; CELL COMMUNICATION; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; MIDDLE AGED; PROTEIN TRANSPORT; PSORIASIS; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; SKIN; TNF-RELATED APOPTOSIS-INDUCING LIGAND; UP-REGULATION;

EID: 79960746061     PISSN: 03403696     EISSN: 1432069X     Source Type: Journal    
DOI: 10.1007/s00403-011-1125-0     Document Type: Article

References (39)

1. F Bachmann SA Buechner M Wernli S Strebel P Erb 2001 Ultraviolet light downregulates CD95 ligand and TRAIL receptor expression facilitating actinic keratosis and squamous cell carcinoma formation J Invest Dermatol 117 59 66 11442750 10.1046/j.0022-202x.2001.01380.x 1:CAS:528:DC%2BD3MXlsFagt70%3D (Pubitemid 32652440)
2. S Brost R Koschny J Sykora W Stremmel F Lasitschka H Walczak, et al. 2010 Differential expression of the TRAIL/TRAIL-receptor system in patients with inflammatory bowel disease Pathol Res Pract 206 43 50 19954896 10.1016/j.prp.2009.09.005
3. SS Cheung DL Metzger X Wang J Huang J Tai AJ Tingle, et al. 2005 Tumor necrosis factor-related apoptosis-inducing ligand and CD56 expression in patients with type 1 diabetes mellitus Pancreas 30 105 114 15714132 10.1097/01.mpa.0000148515.77497.4b 1:CAS:528:DC%2BD2MXjtFWjtrY%3D (Pubitemid 40289448)
4. A Collison PS Foster J Mattes 2009 Emerging role of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) as a key regulator of inflammatory responses Clin Exp Pharmacol Physiol 36 1049 1053 19656161 10.1111/j.1440-1681.2009.05258.x 1:CAS:528:DC%2BD1MXhsFKlt7vI
5. C Falschlehner CH Emmerich B Gerlach H Walczak 2007 TRAIL signalling: decisions between life and death Int J Biochem Cell Biol 39 1462 1475 17403612 10.1016/j.biocel.2007.02.007 1:CAS:528:DC%2BD2sXnslWltbo%3D (Pubitemid 47031030)
6. A Gilhar R Yaniv B Assy S Serafimovich Y Ullmann RS Kalish 2006 Fas pulls the trigger on psoriasis Am J Pathol 168 170 175 16400020 10.2353/ajpath.2006. 041354 1:CAS:528:DC%2BD28XhtVKksbs%3D (Pubitemid 43062570)
7. O Halaas NB Liabakk R Vik C Beninati P Henneke A Sundan, et al. 2004 Monocytes stimulated with group B streptococci or interferons release tumour necrosis factor-related apoptosis-inducing ligand Scand J Immunol 60 74 81 15238075 10.1111/j.0300-9475.2004.01448.x 1:CAS:528:DC%2BD2cXms1aiu78%3D (Pubitemid 38943053)
8. TM Kroll H Bommiasamy RE Boissy C Hernandez BJ Nickoloff R Mestril, et al. 2005 4-Tertiary butyl phenol exposure sensitizes human melanocytes to dendritic cell-mediated killing: relevance to vitiligo J Invest Dermatol 124 798 806 15816839 10.1111/j.0022-202X.2005.23653.x 1:CAS:528:DC%2BD2MXjsVagsrs%3D (Pubitemid 40489508)
9. K Leithner E Stacher R Wurm F Ploner F Quehenberger C Wohlkoenig, et al. 2009 Nuclear and cytoplasmic death receptor 5 as prognostic factors in patients with non-small cell lung cancer treated with chemotherapy Lung Cancer 65 98 104 19081160 10.1016/j.lungcan.2008.10.015
10. Y Liang Z Yang C Li Y Zhu L Zhang R Zhong 2008 Characterisation of TNF-related apoptosis-inducing ligand in peripheral blood in patients with primary biliary cirrhosis Clin Exp Med 8 1 7 18385934 10.1007/s10238-008-0149-z 1:CAS:528:DC%2BD1cXkt1SnsL8%3D (Pubitemid 351666845)
11. MA Lowes AM Bowcock JG Krueger 2007 Pathogenesis and therapy of psoriasis Nature 445 866 873 17314973 10.1038/nature05663 1:CAS:528:DC%2BD2sXhvFGhsr4%3D
12. MA Lowes T Kikuchi J Fuentes-Duculan I Cardinale LC Zaba AS Haider, et al. 2008 Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells J Invest Dermatol 128 1207 1211 18200064 10.1038/sj.jid.5701213 1:CAS:528:DC%2BD1cXksFyhsbs%3D (Pubitemid 351543220)
13. D Mahalingam E Szegezdi M Keane S Jong A Samali 2009 TRAIL receptor signalling and modulation: Are we on the right TRAIL? Cancer Treat Rev 35 280 288 19117685 10.1016/j.ctrv.2008.11.006 1:CAS:528:DC%2BD1MXksVantrY%3D
14. DJ Marble KB Gordon BJ Nickoloff 2007 Targeting TNFalpha rapidly reduces density of dendritic cells and macrophages in psoriatic plaques with restoration of epidermal keratinocyte differentiation J Dermatol Sci 48 87 101 17689932 10.1016/j.jdermsci.2007.06.006 1:CAS:528:DC%2BD2sXhtVCntL7M (Pubitemid 47381571)
15. P Mirandola C Ponti G Gobbi I Sponzilli M Vaccarezza L Cocco, et al. 2004 Activated human NK and CD8+ T cells express both TNF-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors but are resistant to TRAIL-mediated cytotoxicity Blood 104 2418 2424 15205263 10.1182/blood-2004-04-1294 1:CAS:528:DC%2BD2cXovVegtL4%3D (Pubitemid 39331842)
16. FO Nestle DH Kaplan J Barker 2009 Psoriasis N Engl J Med 361 496 509 19641206 10.1056/NEJMra0804595 1:CAS:528:DC%2BD1MXpt1Crsb8%3D
17. V Nguyen C Cudrici V Zernetkina F Niculescu H Rus C Drachenberg, et al. 2009 TRAIL, DR4 and DR5 are upregulated in kidneys from patients with lupus nephritis and exert proliferative and proinflammatory effects Clin Immunol 132 32 42 19349211 10.1016/j.clim.2009.02.011 1:CAS:528:DC%2BD1MXmvFyrt7k%3D
18. S Peternel M Kaštelan 2009 Immunopathogenesis of psoriasis: focus on natural killer T cells J Eur Acad Dermatol Venereol 23 1123 1127 19453772 10.1111/j.1468-3083.2009.03292.x 1:CAS:528:DC%2BC3cXlsVSju7g%3D
19. JZ Qin V Chaturvedi MF Denning P Bacon J Panella D Choubey, et al. 2002 Regulation of apoptosis by p53 in UV-irradiated human epidermis, psoriatic plaques and senescent keratinocytes Oncogene 21 2991 3002 12082529 10.1038/sj.onc.1205404 1:CAS:528:DC%2BD38XjvFejurs%3D (Pubitemid 34522898)
20. X Ren F Ye Z Jiang Y Chu S Xiong Y Wang 2007 Involvement of cellular death in TRAIL/DR5-dependent suppression induced by CD4+CD25+ regulatory T cells Cell Death Differ 14 2076 2084 17762882 10.1038/sj.cdd.4402220 1:CAS:528:DC%2BD2sXhtlajs7nI (Pubitemid 350131157)
21. U Schaefer O Voloshanenko D Willen H Walczak 2007 TRAIL: a multifunctional cytokine Front Biosci 12 3813 3824 17485341 10.2741/2354 1:CAS:528:DC%2BD2sXms1Kmu7w%3D
22. P Secchiero A Gonelli E Carnevale F Corallini C Rizzardi S Zacchigna, et al. 2004 Evidence for a proangiogenic activity of TNF-related apoptosis-inducing ligand Neoplasia 6 364 373 15256058 10.1593/neo.03421 1:CAS:528: DC%2BD2cXmslWlu78%3D (Pubitemid 38924851)
23. P Secchiero C Zerbinati E Rimondi F Corallini D Milani V Grill, et al. 2004 TRAIL promotes the survival, migration and proliferation of vascular smooth muscle cells Cell Mol Life Sci 61 1965 1974 15289937 10.1007/s00018-004-4197-6 1:CAS:528:DC%2BD2cXnsVWgtLY%3D (Pubitemid 39094803)
24. G Stary I Klein S Kohlhofer F Koszik T Scherzer L Müllauer, et al. 2009 Plasmacytoid dendritic cells express TRAIL and induce CD4+ T-cell apoptosis in HIV-1 viremic patients Blood 114 3854 3863 19690337 10.1182/blood-2009-04- 217927 1:CAS:528:DC%2BD1MXhsVSmsbzE
25. S Ständer T Schwarz 2005 Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is expressed in normal skin and cutaneous inflammatory diseases, but not in chronically UV-exposed skin and non-melanoma skin cancer Am J Dermatopathol 27 116 121 15798435 10.1097/01.dad.0000154401. 45465.ee (Pubitemid 40471096)
26. KA Stegmann NK Björkström H Veber S Ciesek P Riese J Wiegand, et al. 2010 Interferon-alpha-induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection Gastroenterology 138 1885 1897 20334827 10.1053/j.gastro.2010.01.051 1:CAS:528:DC%2BC3cXmsFykuro%3D
27. M Sun PJ Fink 2007 A new class of reverse signaling costimulators belongs to the TNF family J Immunol 179 4307 4312 17878324 1:CAS:528:DC%2BD2sXhtVCrtbrN
28. W Tang W Wang Y Zhang S Liu Y Liu D Zheng 2009 TRAIL receptor mediates inflammatory cytokine release in an NF-kappaB-dependent manner Cell Res 19 758 767 19434100 10.1038/cr.2009.57 1:CAS:528:DC%2BD1MXms1OmtLw%3D
29. Tchikov V, Bertsch U, Fritsch J, Edelmann B, Schütze S (2010) Subcellular compartmentalization of TNF receptor-1 and CD95 signaling pathways. Eur J Cell Biol. doi: 10.1016/j.ejcb.2010.11.002
30. HF Tsai JJ Lai AH Chou TF Wang CS Wu PN Hsu 2004 Induction of costimulation of human CD4 T cells by tumor necrosis factor-related apoptosis-inducing ligand: possible role in T cell activation in systemic lupus erythematosus Arthritis Rheum 50 629 639 14872508 10.1002/art.20038 1:CAS:528:DC%2BD2cXhvFeiu78%3D (Pubitemid 38198847)
31. E Vassina M Leverkus S Yousefi LR Braathen HU Simon D Simon 2005 Increased expression and a potential anti-inflammatory role of TRAIL in atopic dermatitis J Invest Dermatol 125 746 752 16185275 10.1111/j.0022-202X.2005. 23878.x 1:CAS:528:DC%2BD2MXhtFChu7zP
32. D von Bubnoff E Andrès F Hentges T Bieber T Michel J Zimmer 2010 Natural killer cells in atopic and autoimmune diseases of the skin J Allergy Clin Immunol 125 60 68 10.1016/j.jaci.2009.11.020
33. J Yang Y Li YQ Liu JW Long F Tian J Dong, et al. 2009 Expression of antiapoptotic protein c-FLIP is upregulated in psoriasis epidermis Eur J Dermatol 19 29 33 19059832
34. N Yawalkar GG Tscharner RE Hunger AS Hassan 2009 Increased expression of IL-12p70 and IL-23 by multiple dendritic cell and macrophage subsets in plaque psoriasis J Dermatol Sci 54 99 105 19264456 10.1016/j.jdermsci.2009.01.003 1:CAS:528:DC%2BD1MXktFWksrc%3D
35. LC Zaba J Fuentes-Duculan NJ Eungdamrong MV Abello I Novitskaya KC Pierson, et al. 2009 Psoriasis is characterized by accumulation of immunostimulatory and Th1/Th17 cell-polarizing myeloid dendritic cells J Invest Dermatol 129 79 88 18633443 10.1038/jid.2008.194 1:CAS:528:DC%2BD1cXhsVymu7%2FK
36. LC Zaba J Fuentes-Duculan NJ Eungdamrong LM Johnson-Huang KE Nograles TR White, et al. 2010 Identification of TNF-related apoptosis-inducing ligand and other molecules that distinguish inflammatory from resident dendritic cells in patients with psoriasis J Allergy Clin Immunol 125 1261 1268.e9 20471070 10.1016/j.jaci.2010.03.018 1:CAS:528:DC%2BC3cXmslekurk%3D
37. LC Zaba JG Krueger MA Lowes 2009 Resident and "inflammatory" dendritic cells in human skin J Invest Dermatol 129 302 308 18685620 10.1038/jid.2008.225 1:CAS:528:DC%2BD1MXmt1Gktg%3D%3D
38. G Zauli A Pandolfi A Gonelli R Di Pietro S Guarnieri G Ciabattoni, et al. 2003 Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) sequentially upregulates nitric oxide and prostanoid production in primary human endothelial cells Circ Res 92 732 740 12649264 10.1161/01.RES.0000067928.83455. 9C 1:CAS:528:DC%2BD3sXislCgurg%3D (Pubitemid 36457637)
39. XD Zhang AV Franco T Nguyen CP Gray P Hersey 2000 Differential localization and regulation of death and decoy receptors for TNF-related apoptosis-inducing ligand (TRAIL) in human melanoma cells J Immunol 164 3961 3970 10754286 1:CAS:528:DC%2BD3cXis1Wlur4%3D (Pubitemid 30215048)